# Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Brazil, Taiwan or Thailand

> **NCT00849381** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 1239 (actual)

## Conditions studied

- Infections, Papillomavirus

## Interventions

- **BIOLOGICAL:** GSK580299, GSK Biological's HPV vaccine

## Key facts

- **NCT ID:** NCT00849381
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 1239 (ACTUAL)
- **Last updated:** 2014-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00849381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00849381, "Safety Study of GSK Biologicals' Human Papillomavirus Vaccine in 580299/008 Subjects From Brazil, Taiwan or Thailand". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00849381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*